Population Pharmacokinetic Modeling in Very Premature Infants Receiving Midazolam during Mechanical Ventilation  Midazolam Neonatal Pharmacokinetics

TC Lee, BG Charles, GJ Harte, PH Gray… - The Journal of the …, 1999 - pubs.asahq.org
Background Midazolam is used widely as a sedative to facilitate mechanical ventilation. This
prospective study investigated the population pharmacokinetics of midazolam in very …

[引用][C] The pharmacokinetics of rectal midazolam for premedication in children

C Saint-Maurice, C Meistelman, E Rey… - The Journal of the …, 1986 - pubs.asahq.org
disaster before any sign of trouble was detected. Page 1 536 no cyanosis, change in breath
sounds, or hemodynamic instability. If the pulse oximeter had not been in use, the case could …

Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity

ST Wiebe, AD Meid, G Mikus - Journal of Pharmacokinetics and …, 2020 - Springer
CYP3A plays an important role in drug metabolism and, thus, can be a considerable liability
for drug-drug interactions. Population pharmacokinetics may be an efficient tool for detecting …

The use of PBPK modeling across the pediatric age range using propofol as a case

R Michelet, J Van Bocxlaer, K Allegaert… - … of Pharmacokinetics and …, 2018 - Springer
The project SAFEPEDRUG aims to provide guidelines for drug research in children, based
on bottom-up and top-down approaches. Propofol, one of the studied model compounds …

Population pharmacokinetics of metoclopramide in infants, children, and adolescents

S Ge, SR Mendley, JG Gerhart… - Clinical and …, 2020 - Wiley Online Library
Metoclopramide is commonly used for gastroesophageal reflux. The aims of the present
study were to develop a pediatric population pharmacokinetic (PopPK) model, which was …

Physiologically based pharmacokinetic modeling for children and its application in pediatric drug research

X ZHENG, S LI, Y YUAN, S JIN, M LI… - Acta Pharmaceutica …, 2020 - pesquisa.bvsalud.org
Physiologically based pharmacokinetic (PBPK) modeling is an important tool to predict
pharmacokinetic or pharmacodynamic profiles in special populations, especially in children …

Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants

S McCann, VE Helfer, SJ Balevic… - The Journal of …, 2024 - Wiley Online Library
Dexmedetomidine is a sedative used in both adults and off‐label in children with
considerable reported pharmacokinetic (PK) interindividual variability affecting drug …

Predicting the changes in oral absorption of weak base drugs under elevated gastric pH using an in vitro–in silico–in vivo approach: case examples—dipyridamole …

A Kambayashi, JB Dressman - Journal of pharmaceutical sciences, 2019 - Elsevier
The aim of the current research was to develop an in silico oral absorption model coupled
with an in vitro dissolution/precipitation testing to predict gastric pH-dependent drug-drug …

Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents

A van Rongen, JD Vaughns, GS Moorthy… - British journal of …, 2015 - Wiley Online Library
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …

A two-way randomized cross-over pharmacokinetic and pharmacodynamic study of an innovative oral solution of midazolam (ADV6209)

C Guittet, M Manso, I Burton, LA Granier… - Pharmaceutical …, 2017 - Springer
Purpose The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …